Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$109,216.00
Nov 1, 2016
Immuno-modulatory HIV-1 nanoparticles as a novel vaccine platform
$180,000.00
Sep 29, 2016
$105,000.00
Sep 1, 2016
Development and therapeutic application of a novel chimpanzee adenovirus-based vaccine against pulmonary tuberculosis
$135,000.00
Jul 1, 2016
Modeling changes in cervical cancer screening performance in the human papillomavirus (HPV) vaccine era and the determinants of HPV transmission
$688,051.00
Jul 1, 2016
Development of novel lung mucosal vaccine for smoking cessation treatment
$875,355.00
Jul 1, 2016
Novel multivalent chimpanzee adenovirus-based vaccines against pulmonary tuberculosis
$100,000.00
Jul 1, 2016
Evaluating the HIV cellular reservoir in preclinical and Phase 1 clinical trial samples after latency reversal with activator vaccines.
$1,402,860.00
Jul 1, 2016
Development of an animal model, a protective vaccine and monoclonal antibodies against Crimean-Congo Hemorrhagic Fever Virus
$8,310,463.00
Jul 1, 2016
Towards a better understanding of Influenza Vaccination: Lessons from the Hutterite Community
$303,101.00
Jul 1, 2016
A Multicentre Study of the Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire for Pre-Exposure Prophylaxis (PREP) In Individuals at Potential Occupational Risk for Ebola Virus Exposure